Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients.

Jakeline Ribeiro BarbosaVanessa Faria CortesMoyra Machado PortilhoJuliana Custódio MiguelVanessa Alves MarquesCristianne Sousa BezerraNatalia Vasconcelos de SouzaDanielle Malta LimaJeová Keny Baima ColaresLia Laura Lewis-XimenezElisabeth LampeLivia Melo Villar

Published in: Journal of clinical pathology (2018)

This study demonstrates good performance of HBsAg and anti-HCV POCTs in CKD patients, especially in serum samples indicating low interference of this disease in the performance of these assays. POCTs could be an important tool for HBV and HCV screening in high-risk populations.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
hepatitis c virus
prognostic factors
peritoneal dialysis
patient reported